What is eosinophilia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Eosinophilia?

Eosinophilia is defined as a peripheral blood eosinophil count greater than 0.5 × 10⁹/L (500 cells/μL), representing an abnormal elevation of eosinophilic white blood cells in the bloodstream. 1

Severity Classification

Eosinophilia is stratified by absolute eosinophil count into clinically meaningful categories:

  • Mild eosinophilia: 500-1,500 cells/μL 2
  • Moderate eosinophilia: 1,500-5,000 cells/μL 2
  • Severe eosinophilia: >5,000 cells/μL 2
  • Hypereosinophilia (HE): Persistent elevation >1.5 × 10⁹/L on two examinations at least one month apart and/or tissue hypereosinophilia 3

The degree of elevation provides diagnostic clues—values >20,000 cells/μL are highly suggestive of myeloproliferative disorders rather than allergic or parasitic causes. 2

Common Causes

Infectious Causes

Helminth (worm) infections are the most common identifiable cause of eosinophilia in returning travelers and migrants, with diagnosis rates ranging from 19-80%. 1, 3 Key parasitic infections include:

  • Strongyloides stercoralis: Can persist lifelong asymptomatically but presents as fatal hyperinfection syndrome (mortality approaching 70%) in immunocompromised patients, even >50 years after initial exposure 3, 4
  • Schistosomiasis: Associated with Katayama syndrome (fever, urticarial rash, eosinophilia) 4-8 weeks after freshwater exposure in endemic areas 4
  • Hookworm, filariasis, and other tissue-migrating helminths: Eosinophilia typically appears 4-12 weeks post-exposure during tissue migration phases 4

Non-Infectious Causes

In countries with low endemic helminth infection rates, the most common causes are: 1

  • Allergic disorders: Asthma, eczema, and hay fever account for approximately 80% of eosinophilia cases in non-tropical populations 4
  • Medications: NSAIDs, beta-lactam antibiotics, and nitrofurantoin are frequent culprits 3, 5
  • Malignancies: Myeloproliferative disorders, lymphomas, and solid tumors 2
  • Autoimmune conditions: Eosinophilic granulomatosis with polyangiitis (EGPA) and other vasculitides 6

Critical distinction: Hypereosinophilia (≥1.5 × 10⁹/L) is never explained by allergy alone and always requires comprehensive workup to exclude secondary causes. 4

Organ-Specific Eosinophilic Disorders

Eosinophilic Esophagitis (EoE): Defined as ≥15 eosinophils per high-power field in esophageal biopsies, presenting with dysphagia/food impaction in adults or feeding problems/vomiting in children 3. This represents a chronic immune/antigen-mediated disease distinct from gastroesophageal reflux disease. 1

Clinical Significance and End-Organ Damage

Even mild persistent eosinophilia can cause significant end-organ damage if left untreated, particularly affecting the heart, lungs, central nervous system, and skin. 1, 3, 5

Cardiac Complications

Eosinophilic myocarditis is the leading cause of morbidity and mortality in hypereosinophilic syndrome, presenting in 20% of cases. 4 Long-standing hypereosinophilia causes damage through release of granule products, lipid mediators, and cytokines from eosinophils. 2

When to Escalate Care

  • Urgent medical assessment required: Any patient with evidence of end-organ damage 1
  • Hematology referral indicated: Eosinophilia ≥1.5 × 10⁹/L persisting >3 months without identified cause after infectious causes have been excluded or treated 1, 4

Important Clinical Pitfalls

Testing for eosinophilia alone is not an adequate screening strategy for helminth infection, as many people with helminth infections do not have eosinophilia. 1, 5 This means you cannot rule out parasitic infection based solely on a normal eosinophil count.

Idiopathic hypereosinophilic syndrome (or idiopathic hypereosinophilic syndrome with end-organ damage) is a diagnosis of exclusion made only after persistent eosinophilia ≥1.5 × 10⁹/L for more than 3 months with no identifiable cause. 1, 7, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Eosinophilia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation of Hypereosinophilia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Eosinophilia Management Guideline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Differential diagnosis of hypereosinophilia].

Zeitschrift fur Rheumatologie, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.